Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid hyperemesis syndrome: A disorder of the HPA axis and sympathetic nervous system?
John R. Richards
Medical Hypotheses (2017) Vol. 103, pp. 90-95
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Cannabinoid Hyperemesis Syndrome: Pathophysiology and Treatment in the Emergency Department
John R. Richards
Journal of Emergency Medicine (2018) Vol. 54, Iss. 3, pp. 354-363
Closed Access | Times Cited: 87
Cannabis use and acute coronary syndrome
John R. Richards, Mary L. Bing, Aimee Moulin, et al.
Clinical Toxicology (2019) Vol. 57, Iss. 10, pp. 831-841
Closed Access | Times Cited: 70
Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment
John R. Richards, Jeff Lapoint, Guillermo Burillo–Putze
Clinical Toxicology (2017) Vol. 56, Iss. 1, pp. 15-24
Closed Access | Times Cited: 65
The association of cannabis use and cardiac dysrhythmias: a systematic review
John R. Richards, Eike Blohm, Kara A. Toles, et al.
Clinical Toxicology (2020) Vol. 58, Iss. 9, pp. 861-869
Closed Access | Times Cited: 62
Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms
Marieka V. DeVuono, Linda A. Parker
Cannabis and Cannabinoid Research (2020) Vol. 5, Iss. 2, pp. 132-144
Open Access | Times Cited: 57
Endocannabinoid signaling in stress, nausea, and vomiting
Marieka V. DeVuono, Thangam Venkatesan, Cecilia J. Hillard
Neurogastroenterology & Motility (2024)
Open Access | Times Cited: 6
Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature
Guillermo Burillo–Putze, John R. Richards, Consuelo Rodríguez‐Jiménez, et al.
Expert Opinion on Pharmacotherapy (2022) Vol. 23, Iss. 6, pp. 693-702
Closed Access | Times Cited: 21
Cannabinoid hyperemesis syndrome: Review of the literature and of cases reported to the French addictovigilance network
Benoît Schreck, Nicolas Wagneur, Pascal Caillet, et al.
Drug and Alcohol Dependence (2017) Vol. 182, pp. 27-32
Closed Access | Times Cited: 35
A Pilot Trial of Topical Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome
Diana Dean, Noor Sabagha, Kaitlin Rose, et al.
Academic Emergency Medicine (2020) Vol. 27, Iss. 11, pp. 1166-1172
Open Access | Times Cited: 32
Mechanisms for the Risk of Acute Coronary Syndrome and Arrhythmia Associated With Phytogenic and Synthetic Cannabinoid Use
John R. Richards
Journal of Cardiovascular Pharmacology and Therapeutics (2020) Vol. 25, Iss. 6, pp. 508-522
Closed Access | Times Cited: 31
Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence
Christopher N. Andrews, Renata Rehak, Matthew Woo, et al.
Alimentary Pharmacology & Therapeutics (2022) Vol. 56, Iss. 11-12, pp. 1532-1542
Closed Access | Times Cited: 17
Distinguishing Clinical Features of Cannabinoid Hyperemesis Syndrome and Cyclic Vomiting Syndrome: A Retrospective Cohort Study
Meera Shah, Andrew Jergel, Roshan George, et al.
The Journal of Pediatrics (2024) Vol. 271, pp. 114054-114054
Closed Access | Times Cited: 3
A Comprehensive Review and Update on Cannabis Hyperemesis Syndrome
Priyadarshini Loganathan, Mahesh Gajendran, Hemant Goyal
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1549-1549
Open Access | Times Cited: 3
Cannabinoid Hyperemesis
Joseph V. Pergolizzi, Jo Ann LeQuang, John Bisney
Medical Cannabis and Cannabinoids (2018) Vol. 1, Iss. 2, pp. 73-95
Open Access | Times Cited: 28
Relation of Cannabis Use and Atrial Fibrillation Among Patients Hospitalized for Heart Failure
Oluwole Adegbala, Adeyinka Adejumo, Olakanmi Olagoke, et al.
The American Journal of Cardiology (2018) Vol. 122, Iss. 1, pp. 129-134
Closed Access | Times Cited: 27
Rare but relevant: Cannabinoid hyperemesis syndrome
Daniel Stjepanović, Jennifer L. Kirkman, Wayne Hall
Addiction (2024)
Closed Access | Times Cited: 2
Cannabis in Gastroenterology: Watch Your Head! A Review of Use in Inflammatory Bowel Disease, Functional Gut Disorders, and Gut-Related Adverse Effects
Yasmin Nasser, Matthew Woo, Christopher N. Andrews
Current Treatment Options in Gastroenterology (2020) Vol. 18, Iss. 4, pp. 519-530
Open Access | Times Cited: 16
Cyclic Vomiting Syndrome and Cannabis Hyperemesis Syndrome
James R. Lathrop, Sheldon N. Rosen, Margaret Heitkemper, et al.
Gastroenterology Nursing (2023) Vol. 46, Iss. 3, pp. 208-224
Closed Access | Times Cited: 6
Death of a young woman with cyclic vomiting: a case report
Ingo von Both, Brittini Santos
Forensic Science Medicine and Pathology (2021) Vol. 17, Iss. 4, pp. 715-722
Closed Access | Times Cited: 13
Role of the stress response and the endocannabinoid system in Δ9-tetrahydrocannabinol (THC)-induced nausea
Marieka V. DeVuono, Olivia La Caprara, Megan T. Sullivan, et al.
Psychopharmacology (2020) Vol. 237, Iss. 7, pp. 2187-2199
Closed Access | Times Cited: 13
Management of Cannabinoid Hyperemesis Syndrome: Focus on Capsaicin
Janice L. Stumpf, Lauren D. Williams
Journal of Pharmacy Practice (2020) Vol. 34, Iss. 5, pp. 786-793
Closed Access | Times Cited: 13
Cannabidiol Interferes with Establishment of Δ9-Tetrahydrocannabinol-Induced Nausea Through a 5-HT1A Mechanism
Marieka V. DeVuono, Olivia La Caprara, Gavin N. Petrie, et al.
Cannabis and Cannabinoid Research (2020) Vol. 7, Iss. 1, pp. 58-64
Open Access | Times Cited: 13
Conditioned gaping produced by high dose Δ9-tetrahydracannabinol: Dysregulation of the hypothalamic endocannabinoid system
Marieka V. DeVuono, Kelly M. Hrelja, Lauren Sabaziotis, et al.
Neuropharmacology (2018) Vol. 141, pp. 272-282
Closed Access | Times Cited: 13
Does cannabidiol induce cannabinoid hyperemesis syndrome?
Hervé Laborde‐Castérot, Islam Amine Larabi, Laurène Dufayet, et al.
Clinical Toxicology (2020) Vol. 58, Iss. 12, pp. 1351-1352
Closed Access | Times Cited: 12
A Case of Cannabinoid Hyperemesis Syndrome with Heliobacter Pylori and Preeclampsia during Pregnancy
Madeline Manning Meurer, Kalyan Chakrala, Dinesh Gowda, et al.
Substance Abuse (2017) Vol. 39, Iss. 1, pp. 9-13
Closed Access | Times Cited: 10
Page 1 - Next Page

Scroll to top